Oxycodone Hydrochloride Market Growth to US $5.68 B by 2034 at 2.68% CAGR
The oxycodone hydrochloride market is expected to grow from US $4.36 billion in 2024 to US $5.68 billion by 2034, at a 2.68% CAGR between 2025 and 2034. Key manufacturers include Mallinckrodt, Pfizer, Teva, Sun Pharma, Lupin, Noramco, Endo. Growth driven by demand in cancer pain management and abuse‑deterrent formulations.